FI851637A0 - 1,4-DIHYDRO-4-OXONAPHTHYRIDINE DERIVATIVES, WITHOUT FRAMSTERATION IN THE DESIGN OF THE OXYTHE ANTIBACTERIA AEMNEN. - Google Patents

1,4-DIHYDRO-4-OXONAPHTHYRIDINE DERIVATIVES, WITHOUT FRAMSTERATION IN THE DESIGN OF THE OXYTHE ANTIBACTERIA AEMNEN.

Info

Publication number
FI851637A0
FI851637A0 FI851637A FI851637A FI851637A0 FI 851637 A0 FI851637 A0 FI 851637A0 FI 851637 A FI851637 A FI 851637A FI 851637 A FI851637 A FI 851637A FI 851637 A0 FI851637 A0 FI 851637A0
Authority
FI
Finland
Prior art keywords
oxythe
framsteration
aemnen
antibacteria
dihydro
Prior art date
Application number
FI851637A
Other languages
Finnish (fi)
Other versions
FI80453B (en
FI851637L (en
FI80453C (en
Inventor
Hirokazu Narita
Yoshinori Konishi
Jun Nitta
Hideyoshi Nagaki
Isao Kitayama
Yoriko Kobayashi
Mikako Shinagawa
Yasuo Watanabe
Akira Yotsuji
Shinzaburo Minami
Isamu Saikawa
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13845280&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI851637(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of FI851637A0 publication Critical patent/FI851637A0/en
Publication of FI851637L publication Critical patent/FI851637L/en
Publication of FI80453B publication Critical patent/FI80453B/en
Application granted granted Critical
Publication of FI80453C publication Critical patent/FI80453C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
FI851637A 1984-04-26 1985-04-25 FOERFARANDE FOER FRAMSTAELLNING AV TERAPEUTISKT AKTIVA 1,4-DIHYDRO-4-OXONAFTYRIDINDERIVAT. FI80453C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8496384 1984-04-26
JP59084963A JPS60228479A (en) 1984-04-26 1984-04-26 1,4-dihydro-4-oxonaphthyridine derivative and salt thereof

Publications (4)

Publication Number Publication Date
FI851637A0 true FI851637A0 (en) 1985-04-25
FI851637L FI851637L (en) 1985-10-27
FI80453B FI80453B (en) 1990-02-28
FI80453C FI80453C (en) 1990-06-11

Family

ID=13845280

Family Applications (1)

Application Number Title Priority Date Filing Date
FI851637A FI80453C (en) 1984-04-26 1985-04-25 FOERFARANDE FOER FRAMSTAELLNING AV TERAPEUTISKT AKTIVA 1,4-DIHYDRO-4-OXONAFTYRIDINDERIVAT.

Country Status (30)

Country Link
JP (1) JPS60228479A (en)
KR (1) KR870001693B1 (en)
AR (1) AR241911A1 (en)
AT (2) AT389698B (en)
AU (2) AU565087B2 (en)
BE (1) BE902279A (en)
CH (1) CH673458A5 (en)
CS (1) CS250684B2 (en)
DD (1) DD238795A5 (en)
DE (2) DE3514076A1 (en)
DK (1) DK165877C (en)
EG (1) EG17339A (en)
ES (2) ES8700256A1 (en)
FI (1) FI80453C (en)
FR (2) FR2563521B1 (en)
GB (2) GB2158825B (en)
HU (2) HU197571B (en)
ID (1) ID21142A (en)
IL (1) IL75021A (en)
IT (1) IT1209953B (en)
LU (1) LU85871A1 (en)
NL (2) NL187314C (en)
NO (1) NO162238C (en)
NZ (1) NZ211895A (en)
PH (3) PH22801A (en)
PL (1) PL147392B1 (en)
PT (1) PT80349B (en)
RO (2) RO95509B (en)
SE (2) SE463102B (en)
ZA (1) ZA853102B (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6172753A (en) * 1984-09-18 1986-04-14 Dainippon Pharmaceut Co Ltd Pyridyl ketone derivative
AT392789B (en) * 1985-01-23 1991-06-10 Toyama Chemical Co Ltd METHOD FOR PRODUCING 1-SUBSTITUTED ARYL-1,4-DIHYDRO-4-OXONAPHTHYRIDINE DERIVATIVES
AU576657B2 (en) * 1985-01-23 1988-09-01 Toyama Chemical Co. Ltd. Naphthyridine and pyridine derivatives
DE3525108A1 (en) * 1985-06-07 1986-12-11 Bayer Ag, 5090 Leverkusen ANTIBACTERIAL EFFECT OF CHINOLON CARBON ACID ESTERS
ATE75740T1 (en) * 1985-06-26 1992-05-15 Daiichi Seiyaku Co PYRIDONECARBONIC ACID DERIVATIVES.
US4962112A (en) * 1987-08-04 1990-10-09 Abbott Laboratories 7-(2-methyl-4-aminopyrrolidinyl)naphthryidine and quinoline compounds
IE62600B1 (en) * 1987-08-04 1995-02-22 Abbott Lab Naphtyridine antianaerobic compounds
US4859776A (en) * 1988-03-11 1989-08-22 Abbott Laboratories (S)-7-(3-aminopyrrolidin-1-yl)-1-(ortho, para-difluorophenyl)-1,4-dihydro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid and method for its preparation
JP2844079B2 (en) * 1988-05-23 1999-01-06 塩野義製薬株式会社 Pyridonecarboxylic acid antibacterial agent
DE3934082A1 (en) * 1989-10-12 1991-04-18 Bayer Ag CHINOLON CARBONIC ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS AN ANTIVIRAL AGENT
WO1992012155A1 (en) * 1991-01-14 1992-07-23 Hanmi Pharmaceutical Co., Ltd. Novel quinolone compounds and processes for preparation thereof
FR2692577B1 (en) * 1992-05-26 1996-02-02 Bouchara Sa NOVEL FLUORINATED QUINOLONES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
KR940014395A (en) * 1992-12-09 1994-07-18 강박광 Novel quinolone derivatives and preparation methods thereof
KR0148277B1 (en) * 1993-01-18 1998-11-02 채영복 Novel fluoroquinolone derivatives and process for the preparation thereof
WO1994025464A1 (en) * 1993-04-24 1994-11-10 Korea Research Institute Of Chemical Technology Novel quinolone carboxylic acid derivatives and process for preparing the same
KR950018003A (en) * 1993-12-09 1995-07-22 스미스클라인 비참 피엘씨 Novel quinolone derivatives and methods for their preparation
EP0787720B1 (en) * 1994-10-20 2003-07-16 Wakunaga Seiyaku Kabushiki Kaisha Pyridonecarboxylate derivative or salt thereof and antibacterial containing the same as active ingredient
ES2224235T3 (en) 1996-04-19 2005-03-01 Wakunaga Pharmaceutical Co., Ltd. NEW DERIVATIVES OF THE PYRIDONACARBOXILIC ACID OR ITS ANTIBACTERIAL SALTS AND AGENTS CONTAINING THE SAME AS ACTIVE INGREDIENTS.
PL332941A1 (en) * 1996-10-30 1999-10-25 Bayer Ag Method of obtaining naphtyridinic compounds and novel intermediate compounds
DE19713506A1 (en) 1997-04-01 1998-10-08 Bayer Ag Process for the preparation of 2,6-dichloro-5-fluoronicotinonitrile and the chemical compound 3-cyano-2-hydroxy-5-fluoropyrid-6-one monosodium salt and its tautomers
KR100768034B1 (en) 1999-03-17 2007-10-17 다이이찌 세이야꾸 가부시기가이샤 Pharmaceutical composition
DE19926400A1 (en) 1999-06-10 2000-12-14 Bayer Ag Improved process for the preparation of 2,6-dichloro-5-fluoro-nicotinic acid and coarse and particularly pure 2,6-dichloro-5-fluoro-nicotinic acid
AU6868700A (en) 1999-09-02 2001-04-10 Wakunaga Pharmaceutical Co., Ltd Quinolinecarboxylic acid derivative or its salt
EP1313708A1 (en) * 2000-08-29 2003-05-28 Chiron Corporation Quinoline antibacterial compounds and methods of use thereof
KR100981351B1 (en) * 2003-10-29 2010-09-10 주식회사 엘지생명과학 Process for preparing 7-chloro-1-cyclopropyl-6- fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
CN101792443A (en) * 2010-03-09 2010-08-04 北京欧凯纳斯科技有限公司 Fluoro-carbostyril derivative as well as preparation method and application thereof
JOP20190045A1 (en) 2016-09-14 2019-03-14 Bayer Ag 7-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereof
CN114369092A (en) * 2021-12-20 2022-04-19 赤峰万泽药业股份有限公司 Tosufloxacin tosylate and preparation method thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2125310A1 (en) * 1971-05-21 1972-11-30 Sterling Drug Inc , New York, NY (V St A) 1-alkyl-1,4-dihydro-4-oxo-1,8-naphtyridine 3-carboxylic acids antibac
AR223983A1 (en) * 1978-08-25 1981-10-15 Dainippon Pharmaceutical Co A PROCEDURE FOR PREPARING 6-HALOGEN-4-OXO-7- (1-PIPERAZINYL) -1,8-NAFTIRIDIN-3-CARBOXYLIC ACID DERIVATIVES
DE3033157A1 (en) * 1980-09-03 1982-04-01 Bayer Ag, 5090 Leverkusen 7-AMINO-1-CYCLOPROPYL-4-OXO-1,4-DIHYDRO-NAPHTHYRIDINE-3-CARBONIC ACIDS, METHOD FOR THE PRODUCTION THEREOF AND THE ANTIBACTERIAL AGENTS CONTAINING THEM
US4382937A (en) * 1981-02-27 1983-05-10 Dainippon Pharmaceutical Co., Ltd. Naphthyridine derivatives and their use as anti-bacterials
IE55898B1 (en) * 1982-09-09 1991-02-14 Warner Lambert Co Antibacterial agents
IL74064A (en) * 1984-01-26 1988-09-30 Abbott Lab 1,7-disubstituted-1,4-dihydro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid derivatives and antibacterial compositions containing them
NZ210847A (en) * 1984-01-26 1988-02-29 Abbott Lab Naphthyridine and pyridopyrimidine derivatives and pharmaceutical compositions
AU576657B2 (en) * 1985-01-23 1988-09-01 Toyama Chemical Co. Ltd. Naphthyridine and pyridine derivatives
DE3525108A1 (en) * 1985-06-07 1986-12-11 Bayer Ag, 5090 Leverkusen ANTIBACTERIAL EFFECT OF CHINOLON CARBON ACID ESTERS

Also Published As

Publication number Publication date
DE3546658C2 (en) 1992-04-02
SE463102B (en) 1990-10-08
NZ211895A (en) 1988-07-28
PH22801A (en) 1988-12-12
DE3514076C2 (en) 1989-03-30
ES542584A0 (en) 1986-09-16
GB2158825B (en) 1989-01-25
PH25046A (en) 1991-01-28
PT80349B (en) 1987-09-30
AU8180487A (en) 1988-03-24
IL75021A (en) 1994-01-25
FR2563521B1 (en) 1989-02-03
RO95509A (en) 1988-09-30
IT1209953B (en) 1989-08-30
NL9100648A (en) 1991-08-01
NO162238B (en) 1989-08-21
HU194226B (en) 1988-01-28
IL75021A0 (en) 1985-08-30
ES551538A0 (en) 1987-07-01
SE8502017L (en) 1985-10-27
EG17339A (en) 1989-06-30
PL147392B1 (en) 1989-05-31
PT80349A (en) 1985-05-01
AT390258B (en) 1990-04-10
IT8548002A0 (en) 1985-04-26
AU4165085A (en) 1985-10-31
NL187314C (en) 1991-08-16
GB8716897D0 (en) 1987-08-26
PL253108A1 (en) 1985-12-17
SE8804586L (en) 1988-12-20
ATA267888A (en) 1989-09-15
NL8501172A (en) 1985-11-18
AU612993B2 (en) 1991-07-25
FR2563521A1 (en) 1985-10-31
ATA122485A (en) 1989-06-15
FR2614620B1 (en) 1990-03-09
GB2191776B (en) 1990-03-28
SE8804586D0 (en) 1988-12-20
RO91871B (en) 1987-07-31
PH25228A (en) 1991-03-27
ES8700256A1 (en) 1986-09-16
NO851643L (en) 1985-10-28
CS250684B2 (en) 1987-05-14
KR850007596A (en) 1985-12-07
BE902279A (en) 1985-10-25
CH673458A5 (en) 1990-03-15
GB2158825A (en) 1985-11-20
RO95509B (en) 1988-10-01
DE3514076A1 (en) 1985-10-31
FI80453B (en) 1990-02-28
AR241911A1 (en) 1993-01-29
DK165877B (en) 1993-02-01
ES8706673A1 (en) 1987-07-01
GB2191776A (en) 1987-12-23
DK185685D0 (en) 1985-04-25
ID21142A (en) 1999-04-29
SE501412C2 (en) 1995-02-13
LU85871A1 (en) 1985-12-16
AU565087B2 (en) 1987-09-03
SE8502017D0 (en) 1985-04-25
JPS60228479A (en) 1985-11-13
AT389698B (en) 1990-01-10
FI851637L (en) 1985-10-27
FR2614620A1 (en) 1988-11-04
DD238795A5 (en) 1986-09-03
GB8510297D0 (en) 1985-05-30
KR870001693B1 (en) 1987-09-24
DK185685A (en) 1985-10-27
NO162238C (en) 1989-12-06
HUT38634A (en) 1986-06-30
JPS6320828B2 (en) 1988-04-30
RO91871A (en) 1987-07-30
FI80453C (en) 1990-06-11
DK165877C (en) 1993-06-21
HU197571B (en) 1989-04-28
ZA853102B (en) 1986-12-30

Similar Documents

Publication Publication Date Title
FI851637A0 (en) 1,4-DIHYDRO-4-OXONAPHTHYRIDINE DERIVATIVES, WITHOUT FRAMSTERATION IN THE DESIGN OF THE OXYTHE ANTIBACTERIA AEMNEN.
FI875490A0 (en) TEREFTALATESTERKOPOLYMERER OCH ANVAENDNING AV DESSA I TVAETTMEDELSKOMPOSITIONER.
FI875001A (en) FOERFARANDE OCH ANORDNING FOER INBLANDNING AV KEMIKALIER I FIBERMASSA.
FI853026A0 (en) FRAMSTAELLNING AV 3-ACYLAMINOIMIDAZOLE / 1,2-C / PYRIDINDERIVAT OCH DERAS THERAPEUTIC TILLAEMPNING.
FI875748A0 (en) FOERFARANDE OCH ANORDNING FOER TORKNING AV FUKTIGT LOESGODS I EN VIRBELBAEDD-TORKANORDNING.
FI813919L (en) FOERFARANDE FOER FRAMSTAELLNING AV NY TERAPEUTISKT ANVAENDBAR 5,5'-AZOBISSALICYLSYRA OCH SALTER DAERAV
FI864827A (en) FOERFARANDE OCH ANORDNING FOER MATANDE AV TRAED I EN BARKNINGSTRUMMA.
DE3773722D1 (en) INOSOSE DERIVATIVES AND THEIR PRODUCTION.
FI884459A0 (en) FOERFARANDE OCH ANORDNING FOER SUPPLERANDE AV MATNINGSVATTEN I HYDROKULTURER MED AVSALTAT VATTEN.
FI854588A0 (en) BENSAMIDER OCH DERAS SALTER.
FI871231A (en) FOERFARANDE FOER ELEKTRONISK EFTERBILDNING AV KLYKOMKOPPLAREN OCH MIKROFON-HOEGTALARTANGENTEN I EN HOEGTALARTELEFON.
FI78596B (en) FOERFARANDE FOER FRAMSTAELLNING AV SKOERDEANGRIPANDE SVAMP OCH I FOERFARANDET ANVAENDBAR FUNGICID KOMPOSITION.
FI840070A (en) FOERFARANDE OCH MATNINGSANORDNING FOER INMATNING AV EN VEDSATS I EN TRYCKSLIPMASKIN.
FI853663A0 (en) FRAMSTAELLNINGSFOERFARANDE FOER 8-HALOGEN-5,6-DIALKOXIKINAZOLINE-2,4-DIONER OCH DERAS SALTER.
FI861961A (en) FOERFARANDE OCH ANORDNING FOER FOERBAETTRANDE AV MALNINGSRESULTATET I EN TRYCKAMMARKVARN.
FI871305A (en) FOERFARANDE OCH KRETSANORDNING FOER REGLERING AV ARBETSPUNKTEN I VIDEOUTGAONGSSTEG.
DE3578557D1 (en) SUBSTITUTED THIOPHEN-2-SULFONAMIDES AND THEIR PRODUCTION.
FI871035A (en) FOERFARANDE FOER FAESTNING AV FAESTORGAN FOER FAESTBESLAG I EN MED OEVERDRAG FOERSEDD SKIVA OCH EN MED FAESTORGAN FOERSEDD SKIVA.
FI860177A0 (en) AVANCERADE EPOXIHARTSER MED FOERBAETTRAD SLAGHAOLLFASTHET I HAERDAD FORM OCH BELAEGGNINGSKOMPOSITIONER FRAMSTAELLDA AV DESSA.
FI875283A (en) FOERFARANDE OCH ANORDNING FOER TEMPERATURREGLERING AV KATALYSATORSKIKT I AMMONIAKFRAMSTAELLNINGSANLAEGGNINGAR.
FI861517A (en) FOERFARANDE OCH ANORDNING FOER FOERDELNING AV FLUIDISERINGSGAS I EN VIRVELBAEDDSREAKTOR.
FI863513A0 (en) SAETT OCH ANORDINATION FOER UTBYTE AV KOKILL I GJUTMASKIN.
ATE44958T1 (en) AZETIDE DERIVATIVES AND THEIR PRODUCTION.
FI864428A (en) FOERFARANDE FOER FRAMSTAELLNING AV SUBSTITUERADE 1,1,2-TRIFENYLBUT-1-ENER OCH I FOERFARANDET ANVAENDBARA MELLANPRODUKTER.
FI860681A0 (en) FOERFARANDE OCH ANORDNING FOER MAETNING AV KARAKTERISTISKA EGENSKAPER I EN SUSPENSION.

Legal Events

Date Code Title Description
FG Patent granted

Owner name: TOYAMA CHEMICAL CO., LTD.

MA Patent expired